PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,818.00
Bid: 2,814.00
Ask: 2,818.00
Change: 34.00 (1.22%)
Spread: 4.00 (0.142%)
Open: 2,788.00
High: 2,818.00
Low: 2,788.00
Prev. Close: 2,784.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

17 Jan 2020 09:26

RNS Number : 1622A
Coca-Cola HBC AG
17 January 2020
 

Coca-Cola HBC AG

Conference call invitation for investors and analysts

2019 full-year results on Thursday, 13 February 2020

 

Zug, Switzerland - 17 January 2020 - Coca-Cola HBC AG (Coca‑Cola HBC) today announces that it will release its 2019 full-year results ended 31 December 2019 on Thursday, 13 February 2020 at 7:00 am London Time. The press release will be available as of that time on the company website: http://www.coca-colahellenic.com

 

Coca-Cola HBC's management will host a conference call for investors and analysts on Thursday, 13 February 2020 at 9:00 am London Time.

 

To join the call, participants should dial one of the following numbers and quote 'Coca‑Cola Hellenic' approximately 10 minutes ahead of the scheduled start time.

 

UK participants - toll free

0808 109 0700

US participants - toll free

1 866 966 5335

Greek participants - toll free

00800 1273 78

 

Swiss participants - toll free

0800 800 038

Standard international

+44 20 3003 2666

 

 

The conference call, which will include management's remarks followed by a question and answer session, will last approximately one hour.

 

Participants can log on to http://coca-colahellenic.com/en/investors/ for a live audio webcast of the conference call.

 

A recording of the call and its transcript will be made available on the Company website following the conference call at http://coca-colahellenic.com/en/investors/financial-results-and-presentations/

 

 

 

Enquiries

Coca‑Cola HBC Group

Joanna Kennedy

Investor Relations Director

 

Tel: +44 20 37 444 230

joanna.kennedy@cchellenic.com

Carla Fabiano

Investor Relations Manager

 

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

David Hart

Group External Communication Director

Tel: +41 41 726 0143

david.hart@cchellenic.com

International media contact:

Teneo

Rob Morgan

Tom Davies

 

Tel: +44 7557 413 275

robert.morgan@teneo.com

tom.davies@teneo.com

Greek media contact:

V+O Communications

Argyro Oikonomou

 

Tel: +30 211 7501219

ao@vando.gr

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, plant based beverages and ready-to-drink tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORSFISUWESSEEF
Date   Source Headline
22nd Jun 20211:19 pmRNSResult of AGM
18th Jun 20212:02 pmRNSDirector/PDMR Shareholding
10th Jun 202111:57 amRNSAthens Exchange trading date of ordinary shares
1st Jun 202111:01 amRNSIssue of equity and total voting rights
21st May 20217:00 amRNSNotice of AGM
18th May 20211:50 pmRNSDirector/PDMR Shareholding
12th May 20217:00 amRNSGood start in a challenging environment
4th May 202110:12 amRNSBlock listing Interim Review
4th May 202110:05 amRNSTotal voting rights
19th Apr 20214:34 pmRNSDirector/PDMR Shareholding
19th Apr 202112:05 pmRNSNotice of Results
1st Apr 20214:09 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:03 pmRNSElection of Home Member State
18th Mar 20215:12 pmRNSDirector/PDMR Shareholding
18th Mar 20212:26 pmRNS2020 integrated annual report 'Adapt to Win'
18th Mar 202112:52 pmRNSDirector/PDMR Shareholding
18th Mar 202112:27 pmRNSDirector/PDMR Shareholding
18th Mar 20219:50 amRNSDirector/PDMR Shareholding
1st Mar 20218:33 amRNSIssue of Equity
18th Feb 202112:14 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSOperational agility delivers resilient performance
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.